Here are eight notes:
1. HCA stock has a $105.00 target price, an increase from their previous target price of $102.00.
2. Oppenheimer’s target price for HCA stock indicates a potential upside of 12.01 percent from HCA’s current price.
3. CMO Jonathan B. Perlin sold 32,010 shares of HCA stock in a transaction occurring Thursday, June 25.
4. The shares sold at an average price of $87.31, for a transaction totaling $2,794,793.
5. CEO R. Milton Johnson additionally sold 140,642 of HCA stock for a transaction totaling $11,798,457. Each share sold for an average price of $83.89.
6. HCA has a one year low of $59.39 and a one year high of $95.49.
7. The stock’s 50-day moving average is $86.71 and its 200-day moving average is $77.31.
8. HCA has a market cap of $38.84 billion and a P/E rating of 19.69.
More on surgery centers:
Barnabas Health & Robert Wood Johnson Health System sign partnership agreement, to include ambulatory centers: 4 key notes
Physicians file CON for new surgery center in Vermont: 4 things to know
Tenet stock trading 6.5% below 52-week average: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
